Lili Zhang

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/acc2b8e0-d37c-11eb-9aaf-2d15ec0e1e68.jpg

First Name

Lili

Last Name

Zhang

NPI

1992066948

Faculty ID

16495

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Non-invasive cardiology, echocardiography, cardio-oncology, multimodality cardiovascular imaging

Research Focus

Cardiotoxicity of cancer therapy, immune checkpoint inhibitor myocarditis, and the application of multimodality imaging and machine-learning techniques in cardiovascular disease.

Elsevier Profile

EMR ID

56187

Biography

<p>Lili Zhang, MD, is Director, Cardio-Oncology Program and Assistant Professor, Cardiology at Montefiore Einstein. A non-invasive cardiologist and a cardiac imaging specialist, Dr. Zhang&rsquo;s clinical focus is in Cardio-Oncology, cardiomyopathy, general cardiology, echocardiography and multimodality cardiac imaging.</p><p>In 2007, Dr. Zhang earned her Doctor of Medicine degree at Peking University, Beijing, China. Further education and postdoctoral training brought her to the U.S., completing her Master of Science in Epidemiology at Johns Hopkins Bloomberg School of Public Health in 2011. She then came to Einstein, completing her residency in internal medicine in 2015 and her fellowship in cardiology in 2018. In 2019, Dr. Zhang completed her fellowship in Cardio-Oncology and cardiac imaging at Massachusetts General Hospital.</p><p>Dr. Zhang&rsquo;s research focuses on cardiotoxicity of cancer therapy, immune checkpoint inhibitor myocarditis, cardiovascular care and the application of multimodality imaging and machine-learning techniques in cardiovascular disease. Her research experience includes retrospective studies, prospective cohorts (ARIC and CHS), large multi-cohort consortiums (CHARGE and PAGE consortiums), randomized clinical trials (PROMISE trial), and international collaborative registries (international immune checkpoint inhibitor myocarditis registry and Global Cardio Oncology Registry). She has shared her work through more than 60 manuscripts in peer-reviewed journals and abstract publications.</p><p>Dr. Zhang is board certified in Internal Medicine and Cardiovascular Disease. She is a Fellow of the American College of Cardiology, and is a member of the American Heart Association and the international Cardio-Oncology Society. In 2021, she was awarded the Glorney-Raisbeck Junior Faculty Research Award in Cardiovascular Disease by New York Academy of Medicine.</p>

Is Open Scheduling

Off

Samson Wiseman

https://assets.montefioreeinstein.org/profiles/images/physphoto/Wiseman_Samson_MD_420x504.jpg

First Name

Samson

Last Name

Wiseman

NPI

1588761316

Faculty ID

10181

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

4748

Is Open Scheduling

Off

Henry Michael Ushay

https://assets.montefioreeinstein.org/profiles/images/physphoto/Ushay_Michael_MD_420x504.jpg

First Name

Henry

Last Name

Ushay

NPI

1558332007

Faculty ID

10275

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Pediatric critical care medicine with a special emphasis on respiratory failure; shock resuscitation; cardiac intensive care; intensive care of pediatric oncology patients; extracorporeal support for children with respiratory and cardiovascular failure

Research Focus

Leadership and direction of the 16-bed Pediatric Critical Care Unit of The Children&rsquo;s Hospital at Montefiore; improving medication safety; respiratory physiology; advances in the management of respiratory failure in children; shock; medical ethics

Elsevier Profile

EMR ID

4763

Biography

<p>Dr. Ushay is Professor of Clinical Pediatrics in the Albert Einstein College of Medicine. He is a Fellow of the American Academy of Pediatrics as well as a Fellow of the American College of Critical Care Medicine. </p><p>After obtaining a PhD in Chemistry from Columbia University, Dr. Ushay received his MD from UMDNJ-New Jersey Medical School and completed a Pediatrics residency in the Montefiore-Jacobi-Einstein program. After serving as Chief Resident and a Fellow in Pediatric Pulmonology at Montefiore, he completed a Pediatric Critical Care Fellowship at New York Hospital/Cornell Medical Center in 1993. He was a faculty member at NewYork-Presbyterian and Memorial Sloan-Kettering Hospitals from 1993 to 2005, and he served as Pediatric Critical Care Medicine Fellowship Program Director and Medical Director of the Pediatric Observation Unit at Memorial Sloan-Kettering Cancer Center. </p><p>In 2005 Dr. Ushay became Director of the Pediatric Critical Care Unit in The Children&rsquo;s Hospital at Montefiore. Dr. Ushay is involved in increasing pediatric ICU surge capacity through the New York City Pediatric Disaster Coalition, serving on its Central Leadership Council and teaching the Pediatric Fundamental Critical Care Support Course. Through the National Institute of Child Health and Human Development, Dr. Ushay works on employing medical countermeasures safely for children in the event of chemical, biological or radiological disaster. Sponsored by Surgeons of Hope and Children&rsquo;s HeartLink, Dr. Ushay has worked as a cardiac intensivist in Cambodia, Africa, China and Nicaragua. </p>

Is Open Scheduling

Off

Heather A. Trivedi

https://assets.montefioreeinstein.org/profiles/images/physphoto/Trivedi_Heather_MD_420x540.jpg

First Name

Heather

Last Name

Trivedi

NPI

1700087665

Faculty ID

10013

CMO Specialties

Clinical Terms

Employment Status

part-time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Non-invasive imaging including transthoracic and transesophageal &#160;echocardiography; stress testing; clinical cardiology; women's health.&#160;</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

4388

Visit Type ID

2497

Is Open Scheduling

On

Kristine E. Torres-Lockhart

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/0b28f080-c3c8-11eb-9ea2-7374238588d1.jpg

First Name

Kristine

Last Name

Torres-Lockhart

NPI

1023467115

Faculty ID

16568

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Kristine Torres-Lockhart, MD, FASAM is an Assistant Professor of Medicine in the Division of General Internal Medicine and Department of Psychiatry and Behavioral Sciences at Montefiore Medical Center and the Albert Einstein College of Medicine, as well as the founding director of the Addiction Consult Service at Montefiore's Weiler Hospital. She is Program Director of the Addiction Medicine Fellowship and Co-Director of the Addiction Medicine rotation for medical trainees. An addiction medicine and internal medicine physician, she leads the development and implementation of health system interventions to improve substance use disorder (SUD) care in acute care settings and transitions of care to post-acute and ambulatory care settings.</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><br />Dr. Torres-Lockhart provides SUD treatment, HIV/AIDS care, hepatitis C treatment, and general internal medicine care at several sites across Montefiore Medical Center, including a community health care center. She also actively teaches and supervises medical students, residents, and fellows. She is double board certified in addiction medicine and internal medicine and credentialed as an HIV specialist by the American Academy of HIV Medicine.&nbsp;<br /><br />Dr. Torres-Lockhart completed her fellowship training in addiction medicine at Montefiore Medical Center. Prior to arriving at Montefiore, she completed her residency training in internal medicine and primary care at Brigham and Women&rsquo;s Hospital in Boston, MA, where she also served as primary care chief medicine resident at the West Roxbury and Jamaica Plain Veterans Affairs Medical Centers. She received her undergraduate degree from Dartmouth College and her medical degree from the Geisel School of Medicine at Dartmouth. She is the PI for a HRSA training grant and co-PI for an OASAS training grant to lead the development of educational opportunities in building the addiction medicine workforce. She currently serves on the Board of Directors for the New York Society of Addiction Medicine previously as Communication Chair and now as Secretary.&nbsp;</p>

Research Areas

Research Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Singh-Tan, S., <strong>Torres-Lockhart, K.</strong>, Jakubowski, A., Lu, T., Starrels, J., De Lima, P., Arnsten, J., Nahvi, S., Southern, W. (2023). Addiction Consult Service and Inpatient Outcomes Among Patients with Alcohol Use Disorder. &nbsp;/J Gen Intern Med/, 1-8. doi:10.1007/s11606-023-08202-7</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Jakukowski, A., Singh-Tan, S., <strong>Torres-Lockhart, K</strong>., Nahvi, S., Stein, M., Fox, A. D., &amp; Lu, T. (2023). Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation. /Addict Sci Clin Pract, 18/(1), 31. doi:10.1186/s13722-023-00386-x</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Calcaterra, S. L., Bottner, R., Martin, M., Englander, H., Weinstein, Z. M., Weimer, M. B., Lambert, E., Ronan, M., Huerta, S., Zaman, T., Ullal, M., Peterkin, A., <strong>Torres-Lockhart, K.</strong>, Buresh, M., O&rsquo;Brien, M., Synder, H., Herzig, S. J. (2022). Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines. /J Hosp Med, 17(9),/679-692/./doi:10.1002/jhm.12908</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><strong>Torres-Lockhart, K.</strong> E., Lu, T. Y., Weimer, M. B., Stein, M. R., &amp; Cunningham, C. O. (2022). Clinical Management of Opioid Withdrawal. /Addiction, 117/(9), 2540-2550. doi:10.1111/add.15818</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Cunningham, C. O., Khalid, L., Deng, Y., <strong>Torres-Lockhart, K.</strong>, Masyukova, M., Thomas, S., Zhang, C., Lu, T. (2022). A comparison of office-based buprenorphine treatment outcomes in Bronx community clinics before versus during the COVID-19 pandemic. /J Subst Abuse Treat, 135/, 108641. doi:10.1016/j.jsat.2021.108641</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Joseph, G., <strong>Torres-Lockhart, K.</strong>, Stein, M. R., Mund, P. A., &amp; Nahvi, S. (2021). Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19. /J Subst Abuse Treat, 122/, 108219. doi:10.1016/j.jsat.2020.108219</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">He, L., <strong>Torres-Lockhart, K.</strong>, Forster, N., Ramakrishnan, S., Greninger, P., Garnett, M. J., McDermott, U., Rothenberg, S.M., Benes, C.H., Ellisen, L. W. (2013). Mcl-1 and FBW7 control a dominant survival pathway underlying HDAC and Bcl-2 inhibitor synergy in squamous cell carcinoma. /Cancer Discov, 3/(3), 324-337. doi:10.1158/2159-8290.CD-12-0417</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Ibrahim, Y. H., Garcia-Garcia, C., Serra, V., He, L., <strong>Torres-Lockhart, K</strong>., Prat, A., Anton, P., Cozar, P., Guzman, M., Grueso, J., Rodriguez, O., Calvo, M.T., Aura, C., Diez, O., Rubio, I.T., Perez, J., Rodon, J., Cortes, J., Ellisen, L.W., Scaltriti, M., Baselga, J. (2012). PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition. /Cancer Discov, 2/(11), 1036-1047. doi:10.1158/2159-8290.CD-11-0348</p>

EMR ID

113089

Biography

<p>Kristine E. Torres-Lockhart, MD, FASAM, is Director, Addiction Medicine Fellowship Program at Montefiore Einstein, Founding Director, Addiction Consult Service at Weiler Hospital and Assistant Professor, General Internal Medicine and Psychiatry and Behavioral Sciences at our Albert Einstein College of Medicine. Dr. Torres-Lockhart is a general internist, primary care provider and addiction medicine specialist. She focuses on caring for people who use substances and people with substance use disorders, providing care in hospital settings and in outpatient clinics.</p><p>After obtaining her Bachelor of Arts in neuroscience from Dartmouth College in 2010, Dr. Torres-Lockhart earned her Doctor of Medicine at the Geisel School of Medicine at Dartmouth in 2016. She completed an internship and residency in internal medicine and primary care at Brigham and Women&rsquo;s Hospital in 2019. Following this, Dr. Torres-Lockhart completed a fellowship in addiction medicine at Montefiore Einstein in 2020.</p><p>Dr. Torres-Lockhart's research focuses on evidence-based and harm-reduction-oriented strategies for addressing substance use disorder care in acute care settings, integration of addiction medicine into medical education and optimizing transitions of care for people who use drugs. She has been principal investigator and co-investigator on funded research projects and her work has been published in numerous peer-reviewed publications. Dr. Torres-Lockhart has also shared her work through numerous invited presentations, abstracts and poster presentations. She is a reviewer for scientific journals, including Addiction Science and Clinical Practice, the Journal of Addiction Medicine, the Journal of Substance Abuse Treatment and the Journal of Hospital Medicine.</p><p>Dr. Torres-Lockhart is board certified by the American Board of Internal Medicine and the American Board of Preventive Medicine with certification in Addiction Medicine. She is a Fellow of the American Society of Addiction Medicine, board member of the New York Society of Addiction Medicine and member of the Association for Multidisciplinary Education and Research in Substance Use and Addiction. In 2022, Dr. Torres-Lockhart received the President&rsquo;s Award at the New York Society of Addiction Medicine&rsquo;s Annual Conference. In 2023, she received the Quality Improvement Champion honor at the United Hospital Fund's Tribute to Excellence in Health Care and was a Rising Star Nominee for the Department of Medicine&rsquo;s Physician Recognition Awards at Montefiore Einstein.</p>

Is Open Scheduling

Off

Alecia M. Thompson

https://assets.montefioreeinstein.org/profiles/images/Thompson_Alecia_MD_420x540.jpg

First Name

Alecia

Last Name

Thompson

NPI

1992930796

Faculty ID

12295

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

CHAM Provider

On

Professional Title

Research Focus

Dr. Thompson-Branch's research has focused on the role of cytokines in bronchopulmonary dysplasia and use of ultrasound to diagnose necrotizing enterocolitis.

Elsevier Profile

EMR ID

5397

Biography

<p>With an emphasis on general pediatrics and neonatology, Dr. Thompson completed her residency at NYU Medical Center in 2007 and fellowship at Yale-New Haven Hospital in 2010. During her fellowship, Dr. Thompson also audited the Robert Wood Johnson Clinical Scholars Program, with an interest in performing clinical research. Her research has focused on the role of cytokines in bronchopulmonary dysplasia and use of ultrasound to diagnose necrotizing enterocolitis. She plans to conduct research on the use of near-infrared spectroscopy to delineate central nervous system pathology in preterm infants and predict short-term neurologic outcomes.</p>

Is Open Scheduling

Off

Nicola Tarantino

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/870a5060-5fa7-11ec-9773-d197dc92a0d8.jpg

First Name

Nicola

Last Name

Tarantino

NPI

1669954558

Faculty ID

17681

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

13854

Visit Type ID

2497

Is Open Scheduling

Off

Zocdoc Link

Nicole J. Sutton

https://assets.montefioreeinstein.org/profiles/images/physphoto/Sutton_Nicole_MD_420x504.jpg

First Name

Nicole

Last Name

Sutton

NPI

1659457505

Faculty ID

10455

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

PubMed.gov URL

EMR ID

4767

Biography

<p>Nicole Jampol Sutton, MD, is Division Chief, Pediatric Cardiology, Director, Invasive Cardiology, Director, Pediatric Pulmonary Hypertension Program, and Interim Codirector, Pediatric Heart Center at Children&rsquo;s Hospital at Montefiore. She is also an Associate Professor of Pediatrics at Montefiore-Einstein. Dr. Sutton&rsquo;s clinical focus is on congenital heart disease, pediatric interventional cardiology, pediatric pulmonary hypertension and adult congenital heart disease.</p><p>After receiving her Bachelor of Arts from Harvard University in 1994, Dr. Sutton attended New York University Medical School, earning her Doctor of Medicine in 1998. She began her postdoctoral training with a three-year pediatric residency at NewYork-Presbyterian Morgan Stanley Children&rsquo;s Hospital, which she completed in 2001. She followed this with a cardiology fellowship at Boston Children&rsquo;s Hospital, acting as Chief Cardiology Fellow in 2004 and Senior Catheterization Fellow in 2005.</p><p>Dr. Sutton&rsquo;s research focuses on improving interventional techniques and on quality improvement in the cardiac catheterization lab, including radiation safety. She is also involved in several clinical trials of medications for the treatment of pulmonary hypertension. Her work has been published in many peer-reviewed journals, books and abstracts. Dr. Sutton is a reviewer for several journals including the <em>American Journal of Cardiology</em>, <em>Pediatric Cardiology</em> and <em>Cardiology in the Young</em>.</p><p>Dr. Sutton is board certified in pediatrics, pediatric cardiology and adult congenital heart disease. She is a member of several professional societies including the American Academy of Pediatrics, the American College of Cardiology and the Society of Cardiac Angiography and Intervention. In 2005, she was winner of the poster competition in clinical science at the American Heart Association Scientific Sessions. </p>

Is Open Scheduling

Off

Leandro N. Slipczuk Bustamante

https://assets.montefioreeinstein.org/profiles/images/Slipczuk_Leandro_MD_2x.jpg

First Name

Leandro

Last Name

Slipczuk Bustamante

NPI

1134431000

Faculty ID

16531

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Clinical focus is the treatment of coronary artery disease, familial hypercholesterolemia and lipid disorders in both prevention and established diseases, cardiometabolic disorders, hypertension, valvular heart disease and heart failure with a comprehensive clinical and multimodality imaging approach.

Research Focus

Dr. Slipczuk&rsquo;s research focus is on the identification of high-risk patients and plaque features, lipid disorders, cardiovascular imaging and valvular heart disease.

Elsevier Profile

EMR ID

113938

Biography

<p>Leandro Slipczuk Bustamante, MD, PhD, FACC is a board certified cardiologist,&nbsp; Director of the Advanced Cardiac Imaging Program and the Cardiovascular Atherosclerosis and Lipid Disorder Center at Montefiore Cardiology Division. Additionally, Dr. Slipczuk is an Assistant Professor at our Albert Einstein College of Medicine. His clinical focus is the treatment of coronary artery disease, familial hypercholesterolemia and lipid disorders in both prevention and established diseases, cardiometabolic disorders, hypertension, valvular heart disease and heart failure with a comprehensive clinical and multimodality imaging approach.</p><p>In 2007, Dr. Slipczuk received his Doctor of Medicine from the University of Buenos Aires. He continued studying at this institution, and in 2010 received his Doctor of Philosophy. Dr. Slipczuk began his postgraduate training with a residency in internal medicine at Einstein Medical Center, which he completed in 2013. He then completed a fellowship in cardiology and advanced cardiovascular imaging in 2016 at Cedars-Sinai Medical Center.</p><p>Dr. Slipczuk&rsquo;s research focus is on the identification of high-risk patients and plaque features, lipid disorders, cardiovascular imaging and valvular heart disease. His work has been published in peer-reviewed journals and articles.</p><p>Dr. Slipczuk is board certified by the American Board of Clinical Lipidology and the American Board of Internal Medicine. He is also board certified in cardiovascular CT, comprehensive adult echocardiography and nuclear cardiology. He is an active member of the National Lipid Association where he is a member of the publications committee as well as the imaging and cardiometabolic working groups. He is also a Fellow of the American College of Cardiology and a member of the Society of Cardiovascular Computed Tomography and the Society for Cardiovascular Magnetic Resonance.</p>

Visit Type ID

2497

Is Open Scheduling

On

Zocdoc Link

Jooyoung (Julia) Shin

https://assets.montefioreeinstein.org/profiles/images/physphoto/Shin_Jooyoung_MD_420x504.jpg

First Name

Jooyoung (Julia)

Last Name

Shin

NPI

1821037961

Faculty ID

10716

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p align="left" style=" word-break: normal; text-align: left;"><span style=" color: black; font-size: 12.0pt; font-family: 'Times New Roman';">Clinical cardiology, specifically end-stage congestive heart failure, mechanical circulatory support, and cardiac transplantation.&#160;&#160;</span></p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Shin's clinical focus is on caring for patients with heart failure, particularly providing expertise in advanced heart failure, heart transplantation, and mechanical circulatory support.

Research Focus

Heart failure treatment is the primary focus of Dr. Shin&rsquo;s research. She is the site principal investigator for the effectiveness of omecamtiv mecarbil/AMG 423 to treat chronic heart failure with reduced ejection fraction (GALACTIC-HF) and multiple cardiac sensors for the management of heart failure (MANAGE-HF) trials.

Elsevier Profile

EMR ID

4843

Biography

<p>Jooyoung Julia Shin, MD, is Fellowship Director, Advanced Heart Failure and Transplant Cardiology Fellowship Program and Associate Professor, Medicine at Montefiore Einstein. Dr. Shin&rsquo;s clinical focus centers on heart failure, cardiac transplantation and mechanical circulatory support.</p><p>After obtaining her Bachelor of Science from the University of Michigan in 1994, Dr. Shin earned her Doctor of Medicine at George Washington University in 1999. She completed an internship and residency in internal medicine at the University of Maryland in 2002 before completing a cardiovascular disease fellowship at Emory University in 2005. Following this, Dr. Shin remained at Emory to complete an additional fellowship in advanced heart failure and transplant cardiology in 2006.</p><p>Dr. Shin&rsquo;s research focuses on fellow education. She has been principal investigator and co-principal investigator on several funded research projects, and she has presented at invited lectures nationwide. Her work has also been published in numerous peer-reviewed journals, and she has been a reviewer for scientific publications, including the <em>Mayo Clinic Proceedings</em>, the <em>American Journal of Cardiology</em> and <em>Pacing and Clinical Electrophysiology</em>, among others.</p><p>Dr. Shin is board certified by the American Board of Internal Medicine in Cardiovascular Disease, Internal Medicine and Advanced Heart Failure and Transplant Cardiology. She is a member of the American College of Cardiology and the International Society for Heart and Lung Transplantation.</p>

Is Open Scheduling

Off